These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 400982)

  • 1. Pharmacokinetics and pharmacodynamics of amitriptyline in depression.
    Coppen A; Ghose K; Jørgensen A
    Prog Neuropsychopharmacol; 1979; 3(1-3):191-9. PubMed ID: 400982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenaline, depressive illness, and the action of amitriptyline.
    Ghose K; Coppen A
    Psychopharmacology (Berl); 1977 Aug; 54(1):57-60. PubMed ID: 410061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a therapeutic plasma level range in amitriptyline treatment of depression.
    Breyer-Pfaff U; Giedke H; Gaertner HJ; Nill K
    J Clin Psychopharmacol; 1989 Apr; 9(2):116-21. PubMed ID: 2723128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amitriptyline and nortriptyline response profiles in unipolar depressed patients.
    Lehmann LS; Bowden CL; Redmond FC; Stanton BC
    Psychopharmacology (Berl); 1982; 77(2):193-7. PubMed ID: 6812139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrocardiographic effects of amitriptyline in therapeutic doses on 24-hr monitoring (Holter) with correlation to plasma levels.
    Sirota P; Ori J; Schild K; Appel S; Brandis S; Zahavi I
    Biol Psychiatry; 1990 May; 27(9):1053-6. PubMed ID: 2334745
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo.
    Thomson J; Rankin H; Ashcroft GW; Yates CM; McQueen JK; Cummings SW
    Psychol Med; 1982 Nov; 12(4):741-51. PubMed ID: 7156248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspects of amitriptyline and nortriptyline plasma levels monitoring in depression.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Zerbi F; Savoldi F
    Psychopharmacology (Berl); 1990; 100(3):334-8. PubMed ID: 2315430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amitriptyline plasma levels and therapeutic response.
    Ziegler VE; Co BT; Taylor JR; Clayton PJ; Biggs JT
    Clin Pharmacol Ther; 1976 Jun; 19(6):795-801. PubMed ID: 773587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels, psychophysiological variables, and clinical response to amitriptyline.
    Breyer-Pfaff U; Gaertner HJ; Giedke H
    Psychiatry Res; 1982 Apr; 6(2):223-34. PubMed ID: 6953461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical response and plasma concentrations of amitriptyline and its metabolite-nortriptyline in depressive patients.
    Miljković B; Pokrajac M; Timotijević I; Varagić V
    Eur J Drug Metab Pharmacokinet; 1996; 21(3):251-5. PubMed ID: 8980924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of zimelidine and amitriptyline in depressive out-patients.
    Syvälahti E; Salminen J; Lehtinen V
    J Int Med Res; 1982; 10(4):250-6. PubMed ID: 6214441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial.
    Altamura AC; De Novellis F; Guercetti G; Invernizzi G; Percudani M; Montgomery SA
    Int J Clin Pharmacol Res; 1989; 9(6):391-6. PubMed ID: 2699465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients.
    Monteleone P; Fabrazzo M
    Pharmacopsychiatry; 1994 Nov; 27(6):238-41. PubMed ID: 7870745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline.
    Vandel S; Vandel B; Sandoz M; Allers G; Bechtel P; Volmat R
    Eur J Clin Pharmacol; 1978 Nov; 14(3):185-90. PubMed ID: 365538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression.
    Bakish D; Wiens A; Ellis J; Alda M; Lapierre Y
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy.
    Steimer W; Zöpf K; von Amelunxen S; Pfeiffer H; Bachofer J; Popp J; Messner B; Kissling W; Leucht S
    Clin Chem; 2005 Feb; 51(2):376-85. PubMed ID: 15590749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients.
    Möller HJ; Berzewski H; Eckmann F; Gonzalves N; Kissling W; Knorr W; Ressler P; Rudolf GA; Steinmeyer EM; Magyar I
    Pharmacopsychiatry; 1993 May; 26(3):75-8. PubMed ID: 8415897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative double-blind controlled study of trimipramine and amitriptyline in major depression: lack of correlation with 5-hydroxytryptamine reuptake blockade.
    Cournoyer G; de Montigny C; Ouellette J; Langlois R; Elie R; Caille G; le Morvan P
    J Clin Psychopharmacol; 1987 Dec; 7(6):385-93. PubMed ID: 3323262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double blind comparison of zimelidine and amitriptyline in endogenous depression.
    Montgomery SA; McAuley R; Rani SJ; Roy D; Montgomery DB
    Acta Psychiatr Scand Suppl; 1981; 290():314-27. PubMed ID: 6452798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort ( Hypericum perforatum ).
    Johne A; Schmider J; Brockmöller J; Stadelmann AM; Störmer E; Bauer S; Scholler G; Langheinrich M; Roots I
    J Clin Psychopharmacol; 2002 Feb; 22(1):46-54. PubMed ID: 11799342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.